Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Head and Neck Neoplasms and MTOR[original query] |
---|
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer 2013 May 119 (10): 1823-31. Fury Matthew G, Sherman Eric, Ho Alan L, Xiao Han, Tsai Frank, Nwankwo Oby, Sima Camelia, Heguy Adrian, Katabi Nora, Haque Sofia, Pfister David |
Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2013 Mar 189 (3): 202-14. Dionysopoulos D, Pavlakis K, Kotoula V, Fountzilas E, Markou K, Karasmanis I, Angouridakis N, Nikolaou A, Kalogeras K T, Fountzilas |
Worldwide prevalence of PI3K-AKT-mTOR pathway mutations in head and neck cancer: A systematic review and meta-analysis. Critical reviews in oncology/hematology 2021 Mar 160 103284. Moura Adriana Castelo de, Assad Daniele Xavier, Amorim Dos Santos Juliana, Porto de Toledo Isabela, Barra Gustavo Barcelos, Castilho Rogerio Moraes, Squarize Cristiane Helena, Guerra Eliete Neves Sil |
Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay. Current oncology (Toronto, Ont.) 2023 10 30 (10): 8902-8915. Michael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, Sotirios P Fortis, Nikolaos Kesesidis, Christos Kakouratos, Ioannis Karakasiliotis, Constantin N Baxevan |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: